Dr. Mark Edward Sienko M.D.
Hematologist-Oncologist | Hematology & Oncology605 E Holland Ave Ste 100 Spokane WA, 99218
Dr. Mark Sienko is a hematologist oncologist practicing in Spokane, WA. Dr. Sienko specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
University of Illinois College of Medicine MD 1989
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
- Medical Oncology
- Biological Therapies
- Bone Marrow Aspiration
- Bone Marrow Biopsy
- Breast Cancer Treatment
- Cancer Pain Management
- Cancer Treatment
- Genetic Testing
- Hematologic Disorder Treatment
- Intrathecal Chemotherapy
- Pet Scan
- University of Texas Southwestern Medical Center at Dallas Hematology/Oncology 2005
Experience & Accolades
- Medical Oncologist/Hematologist2005 - 2006Texas Oncology - Plano West
Dr. Mark Edward Sienko M.D.'s Practice location
Spokane, WA 99218Get Direction
SEQUIM, WA 98382Get Direction
Dr. Mark Edward Sienko M.D.'s reviewsWrite Review
Patient Experience with Dr. Sienko
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
- 'Robocop' Stem Cells Developed to Fight Cancer
Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- Facts About Multiple Myeloma
Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...